BYSTEAPIX — 2481732
Application number
2481732
Type(s)
Standard Characters
Category
Trademark
CIPO Status
FORMALIZED
TM5 status
LIVE/APPLICATION/
Awaiting Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and has not yet been assigned to an examiner.
Filed
2026-06-12
Applicant
AMGEN INC.
One Amgen Center Drive
Thousand Oaks, CA 91320-1799
UNITED STATES OF AMERICA
Agent
SMART & BIGGAR LP
Scotia Plaza, 40 King Street West
40th Floor
Toronto
ONTARIO M5H3Y2
Documents
Index headings
- BYSTEAPIX
Goods (Nice class & Statement)
- 5
- (1) Pharmaceutical preparations for use in the treatment of cancer, oncology, tumors, solid and hematological tumors and growths, hematological and hemolytic diseases and disorders, including bone, joint, vertebral column, intestine, colon, prostate, pancreatic, skin, lung, eye, breast, ovary, cervix, stomach, bladder, kidney, head, brain, neck, and blood diseases and disorders, including castration resistant prostate cancer; Pharmaceutical preparations for use in the treatment of solid tumors and growths, hemolytic diseases and disorders; Pharmaceutical preparations for use in the treatment of metastatic diseases; Pharmaceutical preparations for treating metabolic diseases and disorders; Pharmaceutical preparations for treating inflammatory and autoimmune diseases and diseases; Pharmaceutical preparations for treating or preventing cardiovascular and cerebrovascular diseases and disorders; Pharmaceutical preparations
Claims
- Priority Filing Date: December 17, 2025, Country or Office: UNITED STATES OF AMERICA, Application No. 99553113 in association with the same kind of goods
Action History
| Action | Action date | Due date | Comments |
|---|---|---|---|
| Filed | 2026-06-12 | ||
| Created | 2026-06-12 | ||
| Formalized | 2026-06-12 |